Hamps Bio IPO is a fixed price issue aiming to raise ₹6.22 crores through the issuance of 12.2 lakh shares. The IPO will open for subscription on December 13, 2024, and will close on December 17, 2024. Priced at ₹51 per share, this public offering will be listed on the BSE SME platform, with the tentative listing date set for December 20, 2024. The minimum lot size for retail investors is 2,000 shares, requiring a minimum investment of ₹102,000. For HNI investors, the minimum lot size is 4,000 shares, amounting to ₹204,000. The allotment is expected to be finalized on December 18, 2024. With a strong financial performance, Hamps Bio recorded a revenue of ₹650.13 crores in FY 2024, up from ₹558.49 crores in FY 2023, and a profit of ₹50.07 crores in 2024, a notable increase from ₹35.90 crores in 2023. Given the company’s growth trajectory, this IPO presents a potential opportunity for long-term investors.
Overview of Contents
About Hamps Bio IPO
Incorporated in 2007, Hamps Bio Limited specializes in the marketing and distribution of pharmaceutical products, including tablets, syrups, capsules, injectables, oils, and nutritional supplements. The company operates through a vast distribution network of over 50 distributors and e-commerce platforms like Amazon (US, Canada, EU), Flipkart, and Jio Mart, reaching 8 states and union territories in India. Additionally, their Freeze-dried and Frozen products are sold in 6 countries and 22 states. Hamps Bio’s business is split into two segments: Pharmaceuticals, marketed under the “Hamps” brand, and Freeze-dried and Frozen products under the “FzyEzy” brand. The company offers over 180 products and operates through both B2B and B2C models. Hamps Bio’s competitive strengths include expert leadership, a robust distribution network with e-retailing, a diversified product range, and a strong global customer base with established relationships.
If you’ve applied for the Hamps Bio IPO and are eagerly waiting to check the Hamps IPO allotment status, here’s a detailed step-by-step guide to help you verify it through different platforms, including Bigshare, BSE, your Demat account, and your bank account.
Hamps Bio IPO Details
| IPO Detail | Information |
|---|---|
| IPO Date | December 13, 2024 to December 17, 2024 |
| Listing Date | December 20, 2024 (tentative) |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Fresh Issue | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding Pre-Issue | 3,136,000 shares |
| Shareholding Post-Issue | 4,356,000 shares |
| Market Maker Portion | 62,000 shares |
Hamps Bio IPO Timeline
| Event | Date |
|---|---|
| IPO Open Date | Friday, December 13, 2024 |
| IPO Close Date | Tuesday, December 17, 2024 |
| Basis of Allotment | Wednesday, December 18, 2024 |
| Initiation of Refunds | Thursday, December 19, 2024 |
| Credit of Shares to Demat | Thursday, December 19, 2024 |
| Listing Date | Friday, December 20, 2024 |
| Cut-off Time for UPI Mandate Confirmation | 5 PM on December 17, 2024 |
Hamps Bio IPO Lot Size
Investors can apply for the Hamps Bio IPO in lots, with a minimum lot size of 2,000 shares. The minimum investment for retail investors is ₹102,000, and for HNI investors, it is ₹204,000 for 4,000 shares. Below is a detailed breakdown of the lot sizes and corresponding investments for both retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹102,000 |
| Retail (Max) | 1 | 2,000 | ₹102,000 |
| HNI (Min) | 2 | 4,000 | ₹204,000 |
Hamps Bio IPO Promoter Holding
The promoters of Hamps Bio Limited include Herrik Shah, Shrenik Shah, Pallavi Shah, Mitali Shah, Herrik Shah HUF, and Shrenik Shah HUF. Currently, the promoters hold 100% of the company’s shares, but post-IPO, their combined holding will decrease to 71.99%. This change is due to the fresh issuance of shares in the IPO.
| Shareholding | Pre-Issue | Post-Issue |
|---|---|---|
| Promoter Holding | 100.00% | 71.99% |
Hamps Bio IPO Company Financial Report
Hamps Bio Limited has shown significant growth in its financial performance over the last few years. The company reported a revenue of ₹650.13 crores in 2024, a substantial increase compared to ₹558.49 crores in 2023. Additionally, the profit after tax (PAT) for 2024 stood at ₹50.07 crores, reflecting a strong improvement from ₹35.90 crores in 2023.
| Period Ended | Revenue (₹ in Crores) | Expense (₹ in Crores) | Profit After Tax (₹ in Crores) | Assets (₹ in Crores) |
|---|---|---|---|---|
| 2022 | ₹5.34 | ₹5.24 | ₹0.12 | ₹3.64 |
| 2023 | ₹5.58 | ₹5.23 | ₹0.36 | ₹3.96 |
| 2024 | ₹6.50 | ₹5.85 | ₹0.50 | ₹5.15 |
| October 2024 | ₹4.36 | ₹3.90 | ₹0.34 | ₹6.44 |
Hamps Bio IPO Valuation – FY2024
| Key Performance Indicator (KPI) | Values |
|---|---|
| Return on Equity (ROE) | 21.14% |
| Return on Capital Employed (ROCE) | 18.31% |
| EBITDA Margin | 18.18% |
| Profit After Tax (PAT) Margin | 7.73% |
| Debt to Equity Ratio | 0.31 |
| Earnings Per Share (EPS) | ₹1.76 (Basic) |
| Price/Earnings (P/E) Ratio | 29.01 |
| Return on Net Worth (RoNW) | 14.84% |
| Net Asset Value (NAV) | ₹17.22 |
Objects of the Issue
| Purpose | Details |
|---|---|
| Purchase of plant & machinery for FMCG division | To purchase equipment and machinery for the expansion of the FMCG division. |
| Enhancing the visibility and awareness of the brand | To increase brand visibility through marketing and promotional activities. |
| General corporate purposes | For general corporate expenses, including working capital requirements. |
Hamps Bio IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email:Â ipo@bigshareonline.com
Website:Â https://ipo.bigshareonline.com/ipo_status.html
Company Address
Hamps Bio Limited
2900/112,
GIDC, Near Atul Limited,
Ankleshwar, Bharuch 393 002
Phone: +91 8000006663
Email:Â info@hampsbio.com
Website:Â http://www.hampsbio.com/
Conclusion
The Hamps Bio IPO presents a promising investment opportunity for those looking to invest in a well-established pharmaceutical and FMCG company. With a strong growth trajectory, backed by solid financial performance and a robust distribution network, the company is well-positioned for long-term growth. Investors should consider applying for the IPO, especially those with a long-term investment horizon, given the company’s stable revenue growth and strategic plans for expansion. However, as with any investment, it is crucial to evaluate the risks and consult with a financial advisor before making any decisions.
Hamps Bio IPO – Frequently Asked Questions (FAQs)
What is the Hamps Bio IPO issue size?
The Hamps Bio IPO issue size is ₹6.22 crores, consisting of a fresh issue of 12.2 lakh shares at ₹51 per share.
When does the Hamps Bio IPO open and close?
The IPO opens on December 13, 2024, and closes on December 17, 2024.
What is the price band for the Hamps Bio IPO?
The price band for the Hamps Bio IPO is ₹51 per share.
What is the lot size for the Hamps Bio IPO?
The minimum lot size is 2,000 shares, and investors can apply in multiples of 2,000 shares.
What is the minimum investment for retail investors?
The minimum investment for retail investors is ₹102,000 for 2,000 shares.
Where will the Hamps Bio IPO be listed?
The Hamps Bio IPO will be listed on the BSE SME platform.
What is the expected listing date for the Hamps Bio IPO?
The expected listing date is December 20, 2024.
What are the key objectives of the Hamps Bio IPO?
The funds raised will be used for purchasing plant and machinery for the FMCG division, enhancing brand visibility, and general corporate purposes.
What is the company’s financial performance?
For FY 2024, Hamps Bio reported revenue of ₹650.13 crores and a profit of ₹50.07 crores.
 How can I apply for the Hamps Bio IPO?
Investors can apply for the IPO through their Demat account via the ASBA process or using UPI payment methods.